ProMIS Neurosciences Inc PMN

Healthcare Biotechnology

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational discovery platform-ProMIS and Collective Coordinates-to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Using this approach, the Company is developing novel antibody therapeutics for AD, ALS and MSA. Its product candidates are PMN310, PMN267, and PMN442. The PMN310 is a monoclonal antibody designed to treat AD by selectively targeting toxic, misfolded oligomers of amyloid-beta. PMN267 product candidate targeting ALS. PMN442 is a drug candidate being developed for MSA designed to selectively target and protect against pathogenic a-syn species.

NDAQ:PMN - Post by User

ProMIS Neurosciences Inc > Chumming Away …

<< Previous

Bullboard Posts

Next >>

Post by Mole101on Aug 26, 2021 3:48pm

145 Views

Post# 33770969

Chumming Away …

As expected Anon is the big seller but nice to see strong house buying...

Include ATS trades
From: To:

1,010,827 ($205,699) PMN.TO shares exchanged hands today.

House

Bought

Sold

Net

House 089

Raymond James

Bought	$44,053
Volume	213,512
Average	$0.206

Sold	0
Volume	0
Average	0

Net	$44,053
Volume	213,512

House 068

Leede

Bought	$31,800
Volume	159,000
Average	$0.200

Sold	0
Volume	0
Average	0

Net	$31,800
Volume	159,000

House 085

Scotia

Bought	$30,400
Volume	152,000
Average	$0.200

Sold	0
Volume	0
Average	0

Net	$30,400
Volume	152,000

House 079

CIBC

Bought	$26,413
Volume	128,175
Average	$0.206

Sold	$134
Volume	640
Average	$0.209

Net	$26,279
Volume	127,535

House 022

Fidelity

Bought	$18,552
Volume	90,500
Average	$0.205

Sold	0
Volume	0
Average	0

Net	$18,552
Volume	90,500

House 053

Morgan Stanley

Bought	$18,180
Volume	90,000
Average	$0.202

Sold	$102
Volume	500
Average	$0.204

Net	$18,078
Volume	89,500

House 088

Credential

Bought	$12,300
Volume	60,000
Average	$0.205

Sold	0
Volume	0
Average	0

Net	$12,300
Volume	60,000

House 013

Instinet

Bought	$11,112
Volume	55,000
Average	$0.202

Sold	$4,100
Volume	20,000
Average	$0.205

House 001

Anonymous

Bought	$12,735
Volume	62,000
Average	$0.205

Sold	$186,422
Volume	916,012
Average	$0.204

Net	$-173,687
Volume	-85